| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| SDZ.SW - | HOLD | 0 @ CHF 65.7934 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 65.7934. The average price that SDZ.SW shares were previous bought at was CHF 46.9107. The current market price is 40.3% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 825,927 (USD $1,031,107) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 127 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 127. The average price that MRK.DE shares were previous bought at was EUR 117.731. The current market price is 7.9% higher than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 201,101 (USD $234,132) compared to the previous valuation of Merck KGaA |
| NOVN.SW - | HOLD | 0 @ CHF 124.608 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 124.608. The average price that NOVN.SW shares were previous bought at was CHF 104.297. The current market price is 19.5% higher than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 4,489,203 (USD $5,604,428) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 50.6242 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 50.6242. The average price that NOVO-B.CO shares were previous bought at was DKK 54.3016. The current market price is -6.8% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 1,914,354 (USD $298,315) compared to the previous valuation of Novo Nordisk A/S |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 70.3 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 70.3. The average price that ORNBV.HE shares were previous bought at was EUR 59.669. The current market price is 17.8% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 730,666 (USD $850,680) compared to the previous valuation of Orion Oyj however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 25.73 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 25.73. The average price that PHIA.AS shares were previous bought at was EUR 22.3589. The current market price is 15.1% higher than average price they were purchased at. The value of the holding in PHIA.AS has increased by EUR 61,568 (USD $71,681) compared to the previous valuation of Koninklijke Philips NV however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 48.38 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 48.38. The average price that REC.MI shares were previous bought at was EUR 52.7383. The current market price is -8.3% lower than average price they were purchased at. The value of the holding in REC.MI has increased by EUR 36,774 (USD $42,814) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| RO.SW - | HOLD | 0 @ CHF 379.428 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 379.428. The average price that RO.SW shares were previous bought at was CHF 304.239. The current market price is 24.7% higher than average price they were purchased at. The value of the holding in RO.SW has increased by CHF 170,393 (USD $212,723) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 369.444 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 369.444. The average price that ROG.SW shares were previous bought at was CHF 288.914. The current market price is 27.9% higher than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 2,262,657 (USD $2,824,755) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 82.55 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 82.55. The average price that SAN.PA shares were previous bought at was EUR 87.044. The current market price is -5.2% lower than average price they were purchased at. The value of the holding in SAN.PA has increased by EUR 2,007,171 (USD $2,336,854) compared to the previous valuation of Sanofi SA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 599.098 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 599.098. The average price that LONN.SW shares were previous bought at was CHF 603.713. The current market price is -0.8% lower than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 153,420 (USD $191,533) compared to the previous valuation of |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 47.05 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 47.05. The average price that SHL.DE shares were previous bought at was EUR 47.1994. The current market price is -0.3% lower than average price they were purchased at. The value of the holding in SHL.DE has increased by EUR 93,219 (USD $108,530) compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 14.0162 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 14.0162. The average price that SN.L shares were previous bought at was GBP 13.6992. The current market price is 2.3% higher than average price they were purchased at. The value of the holding in SN.L has increased by GBP 101,547 (USD $136,345) compared to the previous valuation of Smith & Nephew PLC however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| SOBI.ST - | HOLD | 0 @ SEK 31.9047 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 31.9047. The average price that SOBI.ST shares were previous bought at was SEK 26.7864. The current market price is 19.1% higher than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 100,815 (USD $10,932) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 238.243 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 238.243. The average price that SOON.SW shares were previous bought at was CHF 260.436. The current market price is -8.5% lower than average price they were purchased at. The value of the holding in SOON.SW has increased by CHF 20,246 (USD $25,276) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 252.2 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 252.2. The average price that SRT3.DE shares were previous bought at was EUR 217.069. The current market price is 16.2% higher than average price they were purchased at. The value of the holding in SRT3.DE has fallen by EUR 175,110 (USD $203,872) compared to the previous valuation of Sartorius AG |
| STMN.SW - | HOLD | 0 @ CHF 107.022 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 107.022. The average price that STMN.SW shares were previous bought at was CHF 109.888. The current market price is -2.6% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 38,853 (USD $48,505) compared to the previous valuation of |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ EUR 232 | EUR 0 | The current share valuation price of TUB.BR based on adjusted close was EUR 232. The average price that TUB.BR shares were previous bought at was EUR 210.25. The current market price is 10.3% higher than average price they were purchased at. The value of the holding in TUB.BR has increased by EUR 106,356 (USD $123,825) compared to the previous valuation of Financiere de Tubize SA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 259.6 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 259.6. The average price that UCB.BR shares were previous bought at was EUR 189.972. The current market price is 36.7% higher than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 606,458 (USD $706,070) compared to the previous valuation of UCB SA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 36.97 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 36.97. The average price that FME.DE shares were previous bought at was EUR 45.9708. The current market price is -19.6% lower than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 464,468 (USD $540,758) compared to the previous valuation of Fresenius Medical Care AG |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 690.8 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 690.8. The average price that ARGX.BR shares were previous bought at was EUR 585.67. The current market price is 18.0% higher than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 338,346 (USD $393,920) compared to the previous valuation of Argenx SE |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 165.563 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 165.563. The average price that AZN.L shares were previous bought at was GBP 132.331. The current market price is 25.1% higher than average price they were purchased at. The value of the holding in AZN.L has increased by GBP 5,511,610 (USD $7,400,319) compared to the previous valuation of AstraZeneca PLC however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 41.67 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 41.67. The average price that BAYN.DE shares were previous bought at was EUR 25.5091. The current market price is 63.4% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 2,377,486 (USD $2,767,995) compared to the previous valuation of Bayer AG however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 108.1 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 108.1. The average price that BIM.PA shares were previous bought at was EUR 114.199. The current market price is -5.3% lower than average price they were purchased at. The value of the holding in BIM.PA has increased by EUR 3,654 (USD $4,254) compared to the previous valuation of BioMerieux however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| COLO-B.CO - | HOLD | 0 @ DKK 76.6623 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 76.6623. The average price that COLO-B.CO shares were previous bought at was DKK 83.2028. The current market price is -7.9% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 53,214 (USD $8,292) compared to the previous valuation of |
| DEMANT.CO - | HOLD | 0 @ DKK 31.2378 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 31.2378. The average price that DEMANT.CO shares were previous bought at was DKK 32.2794. The current market price is -3.2% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 4,835 (USD $753) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 209.7 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 209.7. The average price that DIM.PA shares were previous bought at was EUR 192.964. The current market price is 8.7% higher than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 130,065 (USD $151,429) compared to the previous valuation of Sartorius Stedim Biotech |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 279.4 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 279.4. The average price that EL.PA shares were previous bought at was EUR 263.173. The current market price is 6.2% higher than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 373,569 (USD $434,929) compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 72 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 72. The average price that ERF.PA shares were previous bought at was EUR 57.6515. The current market price is 24.9% higher than average price they were purchased at. The value of the holding in ERF.PA has fallen by EUR 117,339 (USD $136,612) compared to the previous valuation of Eurofins Scientific SE |
| ALC.SW - | HOLD | 0 @ CHF 68.4346 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 68.4346. The average price that ALC.SW shares were previous bought at was CHF 73.8693. The current market price is -7.4% lower than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 326,472 (USD $407,575) compared to the previous valuation of |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 51.98 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 51.98. The average price that FRE.DE shares were previous bought at was EUR 42.6885. The current market price is 21.8% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 277,650 (USD $323,255) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| GALD.SW - | HOLD | 0 @ CHF 173.502 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 173.502. The average price that GALD.SW shares were previous bought at was CHF 132.226. The current market price is 31.2% higher than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 410,603 (USD $512,607) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 301.269 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 301.269. The average price that GMAB.CO shares were previous bought at was DKK 209.088. The current market price is 44.1% higher than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 760,630 (USD $118,530) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 11.675 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 11.675. The average price that GRF.MC shares were previous bought at was EUR 10.6752. The current market price is 9.4% higher than average price they were purchased at. The value of the holding in GRF.MC has increased by EUR 201,612 (USD $234,727) compared to the previous valuation of Grifols SA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 21.7024 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 21.7024. The average price that GSK.L shares were previous bought at was GBP 17.4295. The current market price is 24.5% higher than average price they were purchased at. The value of the holding in GSK.L has increased by GBP 987,792 (USD $1,326,287) compared to the previous valuation of GlaxoSmithKline PLC however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 18.0843 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 18.0843. The average price that HIK.L shares were previous bought at was GBP 22.3835. The current market price is -19.2% lower than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 51,472 (USD $69,110) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.22506 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.22506. The average price that HLN.L shares were previous bought at was GBP 4.39824. The current market price is -3.9% lower than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 359,434 (USD $482,604) compared to the previous valuation of Haleon PLC however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 136.3 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 136.3. The average price that IPN.PA shares were previous bought at was EUR 110.554. The current market price is 23.3% higher than average price they were purchased at. The value of the holding in IPN.PA has increased by EUR 295,055 (USD $343,519) compared to the previous valuation of Ipsen SA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |